tiprankstipranks
Immunovia AB (IMMVF)
:IMMVF
US Market

Immunovia AB (IMMVF) Financial Statements

Compare
36 Followers

Immunovia AB Financial Overview

Immunovia AB's market cap is currently $10.33M. The company's EPS TTM is $-0.149; its P/E ratio is ―; Immunovia AB is scheduled to report earnings on February 25, 2025, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Dec 21Dec 20Dec 19Dec 18Dec 17
Income Statement
Total Revenue
Gross Profit$ 15.81M$ 40.38M$ 27.07M$ 25.39M$ 24.19M
Operating Income$ -166.74M$ -134.68M$ -114.35M$ -88.23M$ -45.58M
EBITDA$ -135.47M$ -134.85M$ -104.75M$ -83.75M$ -43.96M
Net Income$ -155.97M$ -146.03M$ -114.52M$ -86.54M$ -45.23M
Balance Sheet
Cash & Short-Term Investments$ ―$ ―$ ―$ ―$ ―
Total Assets$ 493.81M$ 661.18M$ 419.37M$ 477.38M$ 250.77M
Total Debt$ 33.26M$ 33.13M$ 38.07M$ 0.00$ 0.00
Net Debt$ -254.14M$ -435.33M$ -225.28M$ -386.14M$ -192.43M
Total Liabilities$ 59.91M$ 61.77M$ 61.76M$ 15.43M$ 13.97M
Stockholders' Equity$ ―$ ―$ ―$ ―$ ―
Cash Flow
Free Cash Flow$ -176.83M$ -168.20M$ -128.55M$ -121.40M$ -77.60M
Operating Cash Flow$ -152.65M$ -120.70M$ -91.95M$ -84.11M$ -46.32M
Investing Cash Flow
Financing Cash Flow
Currency in USD

Immunovia AB Earnings and Revenue History

Immunovia AB Debt to Assets

Immunovia AB Cash Flow

Immunovia AB Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis